FeelGood vs Hims: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hims beats FeelGood overall, scoring 7.9/10 vs 7/10. FeelGood is more affordable at $149/mo vs $199/mo. Choose FeelGood for budget-conscious cash-pay patients who want low-cost compoun. Choose Hims for men who want a well-known publicly-traded brand and fda-appr.
A side-by-side comparison of FeelGood and Hims covering pricing, scores, medication types, insurance, and more to help you decide.
FeelGood
#48 of 49Telehealth platform offering compounded semaglutide as both a weekly injection ($149/mo starting) and a daily oral tablet ($249/mo starting), plus a premium brand-name 'original' semaglutide injection option ($1,999/mo). Cash-pay only, no insurance billing, HSA/FSA eligible. LegitScript-approved. FeelGood does not publicly disclose which states it serves, its compounding pharmacy, or its medical leadership.
Visit FeelGoodHims
#12 of 49The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership — alongside their existing compounded semaglutide program. Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026) — significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28% — the highest 1-star rate in our table — clustered around subscription/billing complaints.
Visit Hims| Feature | FeelGood | Hims |
|---|---|---|
| Our Score | 7/10 | 7.9/10 |
| Starting Price | $149/mo | $199/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Budget-conscious cash-pay patients who want low-cost compounded semaglutide — injection or oral tablet — with free shipping, no membership fees, and a money-back weight-loss guarantee | Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership — but should know going in that Hims' customer-experience signal is weaker than smaller competitors |
| Ranking | #48 | #12 |
Pros & Cons Compared
FeelGood
Pros
- +Compounded semaglutide injection from $149/mo with free shipping and no separate membership or consultation fee
- +Offers an oral compounded semaglutide tablet ($249/mo) for needle-averse patients — a non-injectable route only a handful of platforms provide
- +LegitScript-approved — independent certification that the telehealth/pharmacy operation meets legal and safety standards, which many budget compounded shops lack
- +Money-back weight-loss guarantee plus unlimited 24/7 messaging and appointments included
Cons
- −Does NOT publicly disclose which US states it serves — you can't confirm availability in your state before starting an intake
- −$149 is a 'starting' price (dose-escalating), not flat across all doses — your cost can rise as your dose titrates up, and FeelGood doesn't publish the full dose-by-dose schedule
- −Brand-name 'original' semaglutide injection at $1,999/mo is far above market — NovoCare direct Wegovy is $349/mo and Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership. Never buy brand-name through FeelGood
- −No named medical director, prescribing physicians, compounding pharmacy, founding year, or headquarters disclosed on the site — thin corporate and clinical transparency
- −Self-reported '4.8/5' rating is not tied to a named third-party platform (no linked Trustpilot/BBB), so it can't be independently verified; the advertised '15–20% weight loss' figures are FeelGood's marketing, not FDA-reviewed efficacy data
- −Compounded GLP-1s are not FDA-approved (none are) — and FeelGood offers compounded semaglutide only, no tirzepatide
Hims
Pros
- +Publicly traded company (NYSE: HIMS) — SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership — FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
- +Polished app and web experience — among the best user interfaces in men's telehealth.
- +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461) — significant real-world adoption.
Cons
- −Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026) — significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −28% of Trustpilot reviews are 1-star — the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss) — not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −'Hims Oral Kit' is NOT a GLP-1 — it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
- −Brand Wegovy at $599/mo is not competitive with LillyDirect/NovoCare cash prices or with Hers ($149/mo for the same product via the same Novo partnership).
- −Generic high-volume support — large patient base means less personalized attention than smaller competitors.
Our Verdict
Hims edges out FeelGood with a score of 7.9/10 vs 7/10. If budget is your priority, FeelGood starts at $149/mo compared to Hims's $199/mo. Choose FeelGood if you want: budget-conscious cash-pay patients who want low-cost compounded semaglutide — injection or oral tablet — with free shipping, no membership fees, and a money-back weight-loss guarantee. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership — but should know going in that hims' customer-experience signal is weaker than smaller competitors.
Still undecided? Editor's #1 Overall Pick
Embody
$299/mo · 7.3/10 · Compounded
If neither FeelGood nor Hims feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.
Read Full Reviews
Related comparisons
Other matchups readers comparing FeelGood or Hims tend to look at next.
- FeelGood vs TMates$158/mo
- FeelGood vs Gala$149/mo
- FeelGood vs Oak Longevity$130/mo
- Hims vs Hers$199/mo
- Hims vs Shed$199/mo
- Hims vs Henry Meds$199/mo